Concord Biotech Limited — Important, 20-02-2025: General Updates

Concord Biotech Limited has successfully completed an inspection by the Ministry of Food and Drug Safety (MFDS) at its Manufacturing Unit I in Dholka, Gujarat. The inspection took place over three days from February 18 to February 20, 2025. This accomplishment highlights the company's commitment to maintaining high-quality standards and reinforces its leadership position in the industry. The passage of this inspection is likely to positively impact the company's reputation and operational capabilities, offering a further assurance of quality to its customers. This development should be closely monitored by investors, as it underscores potential growth opportunities for the firm.